angiotensin ii has been researched along with Calcinosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, S; Jang, Y; Jeong, J; Lee, BS; Lim, S; Park, S; Seo, M | 1 |
| Arshad, M; Böckler, D; Dihlmann, S; Hakimi, M; Wortmann, M | 1 |
| Bavaria, JE; Branchetti, E; Ferrari, G; Gorman, JH; Gorman, RC; Grau, JB; Lai, EK; Poggio, P; Sacks, MS | 1 |
| Chen, Z; Hu, W; Li, Y; Shen, Y; Xie, C | 1 |
| Campbell, IC; Oshinski, JN; Suever, JD; Taylor, WR; Veneziani, A; Virmani, R; Vito, RP; Weiss, D | 1 |
| Hara, S | 1 |
1 review(s) available for angiotensin ii and Calcinosis
| Article | Year |
|---|---|
[Uremic syndrome: Pathogenesis, pathophysiology, and therapy].
Topics: Amyloidosis; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Calcinosis; Calcium Channel Blockers; Charcoal; Dialysis; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Hypertension; Kidney Failure, Chronic; Toxins, Biological; Uremia; Vascular Diseases | 2006 |
5 other study(ies) available for angiotensin ii and Calcinosis
| Article | Year |
|---|---|
Soluble RAGE attenuates Ang II-induced arterial calcification via inhibiting AT1R-HMGB1-RAGE axis.
Topics: Angiotensin II; Animals; Atherosclerosis; Calcinosis; Calcium; HMGB1 Protein; Mice; Mice, Knockout; Receptor for Advanced Glycation End Products | 2022 |
Deficiency in Aim2 affects viability and calcification of vascular smooth muscle cells from murine aortas and angiotensin-II induced aortic aneurysms.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Calcinosis; Cell Proliferation; Cell Survival; Cellular Senescence; Disease Models, Animal; Disease Susceptibility; DNA-Binding Proteins; Inflammasomes; Mice; Mice, Knockout; Myocytes, Smooth Muscle | 2020 |
Osteopontin-CD44v6 interaction mediates calcium deposition via phospho-Akt in valve interstitial cells from patients with noncalcified aortic valve sclerosis.
Topics: Angiotensin II; Animals; Aortic Valve; Aortic Valve Stenosis; Bioreactors; Bone Morphogenetic Protein 4; Calcinosis; Calcium; Cell Transdifferentiation; Disease Models, Animal; Disease Progression; Humans; Hyaluronan Receptors; Male; Mice; Mice, Inbred C57BL; Osteogenesis; Osteopontin; Phosphorylation; Protein Interaction Mapping; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Signal Transduction | 2014 |
Angiotensin II promotes an osteoblast-like phenotype in porcine aortic valve myofibroblasts.
Topics: Actins; Alkaline Phosphatase; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Valve; Bone Morphogenetic Protein 2; Calcinosis; Cell Transdifferentiation; Cells, Cultured; Myofibroblasts; Osteoblasts; Phenotype; Swine; Valsartan; Wnt Signaling Pathway | 2016 |
Biomechanical modeling and morphology analysis indicates plaque rupture due to mechanical failure unlikely in atherosclerosis-prone mice.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Biomechanical Phenomena; Calcinosis; Computer Simulation; Dietary Fats; Humans; Image Processing, Computer-Assisted; Mice; Mice, Knockout; Models, Biological; Phenotype; Plaque, Atherosclerotic; Receptors, LDL; Stress, Mechanical | 2013 |